April 14, 2022
by Andrii Buvailo
Interview
Dr. Tony Kulesa is the co-founder of Petri, an organization that both invests in early-stage biotech startups and works 1-on-1 …
March 22, 2022
by Andrii Buvailo
Interview
Sponsored by PharmCADD
The application of Artificial Intelligence (AI) to accelerate and improve drug discovery has been a growing trend for several years …
Jan. 7, 2024
by Dana Sokolova
Biopharma insight
With over half of the world's population being female, it's only natural that the world of femtech is experiencing a …
June 29, 2023
by Irina Bilous
Biopharma insight
Artificial Intelligence (AI) is steadily making its presence felt across various sectors, including the pharmaceutical industry. Among the multiple applications …
April 23, 2024
by Andrii Buvailo, PhD
News
As first reported by Endpoints News, Xaira Therapeutics has emerged as one of the most significantly funded new entrants in …
Nov. 14, 2022
by BiopharmaTrend
Biopharma insight
The community of AI-driven biotech companies is continuously expanding, adding new players to the drug discovery race. In 2021 several …
June 23, 2023
by Dana Sokolova
Biopharma insight
The field of 3D bioprinting has emerged as a remarkable technological advancement in recent years. This revolutionary technique involves the …
Aug. 15, 2022
by Andrii Buvailo
Interview
Luciano Santollani is currently working towards his PhD at MIT developing novel cancer therapeutics, and is also working as a …
Jan. 26, 2022
by Andrii Buvailo
Biopharma insight
Artificial Intelligence (AI) in drug discovery is now on a steep rise. A growing number of companies compete to develop …
Nov. 3, 2022
by Bohdana Sokolova
Biopharma insight
While Spain's biotechnology research centers, including the University of Barcelona and Pompeu Fabra University, retain their positions in world rankings, …
July 12, 2022
by Natalia Honchar
News
Receptor.AI, a UK-based start-up company which integrates artificial intelligence (AI) into drug discovery, just announced the public launch of the …
We at Receptor.AI are excited to present the next important milestone in the development of our next-generation AI docking model, …